[Effect of thyrotoxicosis on adrenergic receptors, cyclic adenosine monophosphate, glycogen and enzymes of the myocardium].
In the heart the interaction of the thyroid hormones, the catecholamines and the effect of the beta-blocker was studied. The binding of the radioactive noradrenalin (3H-NA) was higher in the particles of the thyreotoxic myocardium of the dog got by centrifugation at 1,000 and 78,000 g. The 3H-NA-binding was inhibited with propranolol, isoprenalin and in lower concentrations with trimepranol in dogs and also in rats. In the myocardium of the thyreotoxic dogs 3H-NA was less superseded with isoprenalin, in the myocardium of thyreotoxic rats less with non-active norarenalin in comparison to euthyroid animals. The thyreotoxicosis caused an increase of the activities of phosphorylase, of the lipases, of the calcium-dependent ATPase, the protein kinase in presence of histone, further a decrease of the activity of adenyl cyclase, particularly in presence of sodium fluoride and a decrease of the concentration of the cyclic adenosine monophosphate in the myocardium of the rats and dogs, respectively. The pharmacological thyreotoxicosis decreased the concentration of the heart glycogen. This decrease was inhibited by the beta-blocker trimepranol, but not by the alpha-blocker phentolamine. Three possibilities of the explanation of the findings of this complex study are cited. The influence of the thyroid hormones and beta-blockers 1. on the transport and calcium metabolism, 2. on the synthesis of the heart proteins, 3. on the backbinding control of the hormonal effect at cellular level.
D000818:Animals; D000252:Calcium-Transporting ATPases / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism*; D004285:Dogs; D006003:Glycogen / Q000378:metabolism*; D006980:Hyperthyroidism / Q000378:metabolism*; D007545:Isoproterenol / Q000494:pharmacology; D008049:Lipase / Q000378:metabolism; D008297:Male; D014290:Metipranolol / Q000494:pharmacology; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D010646:Phentolamine / Q000494:pharmacology; D006005:Phosphorylases / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000378:metabolism*; D011943:Receptors, Adrenergic, beta / Q000378:metabolism*
D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D006003:Glycogen; D011433:Propranolol; D000242:Cyclic AMP; D006005:Phosphorylases; D008049:Lipase; D000252:Calcium-Transporting ATPases; D007545:Isoproterenol; D014290:Metipranolol; D009638:Norepinephrine; D010646:Phentolamine
Einfluss der Thyreotoxikose auf adrenerge Rezeptoren, zyklisches Adenosinmonophosphat, Glykogen und Enzyme in Myokard.